Future directions in regulatory affairs

O Chisholm, H Critchley - Frontiers in Medicine, 2023 - frontiersin.org
The field of regulatory affairs deals with the regulatory requirements for marketing
authorization of therapeutic products. This field is facing a myriad of forces impacting all …

COVID‐19: a catalyst to accelerate global regulatory transformation

J Stewart, P Honig, L AlJuburi, D Autor… - Clinical …, 2021 - Wiley Online Library
BACKGROUND Previous public health crises have changed medical product development
and regulatory practices. These examples include major legislative amendments and …

[HTML][HTML] Regulatory agilities in the time of COVID-19: overview, trends, and opportunities

WR Bolislis, ML De Lucia, F Dolz, R Mo, M Nagaoka… - Clinical …, 2021 - Elsevier
Purpose Critical steps have been adopted by health and regulatory authorities around the
world to respond to the COVID-19 pandemic. The authors aim to highlight these by providing …

[引用][C] Medical product development and regulatory science for the 21st century: the critical path vision and its impact on health care

S Buckman, SM Huang… - Clinical Pharmacology & …, 2007 - Wiley Online Library
The 21st century will be an unprecedented century of change in drug development and
regulatory science. With major technological advances, such as we've seen in genomics …

Digital innovation in medicinal product regulatory submission, review, and approvals to create a dynamic regulatory ecosystem—are we ready for a revolution?

JC Macdonald, DC Isom, DD Evans, KJ Page - Frontiers in Medicine, 2021 - frontiersin.org
The pace of scientific progress over the past several decades within the biological, drug
development, and the digital realm has been remarkable. The'omics revolution has enabled …

Regulation and innovation: role of regulatory science in facilitating pharmaceutical innovation

P Honig, L Zhang - Clinical Pharmacology & Therapeutics, 2019 - Wiley Online Library
Regulatory science is defined as science and research intended to inform decision making
in a regulatory framework. This issue of Clinical Pharmacology & Therapeutics and the …

Drug development post COVID-19 pandemic: toward a better system to meet current and future global health challenges

KG Aghila Rani, MA Hamad, DM Zaher… - Expert Opinion on …, 2021 - Taylor & Francis
Introduction: Despite advances in drug research and development, our knowledge of the
underlying molecular mechanisms of many diseases remains inadequate. This have led to …

COVID-19: regulatory landscape of medicinal and medical device products for human use

P Beninger - Clinical therapeutics, 2020 - Elsevier
Against the backdrop of the COVID pandemic, the scientific and medical communities are
working with all deliberate speed with state-of-the-art technologies to develop diagnostic …

Regulatory flexibilities and guidances for addressing the challenges of COVID-19 in the EU: what can we learn from company experiences?

K Klein, P Stolk, P Tellner, V Acha, S Montagne… - … Innovation & Regulatory …, 2022 - Springer
The COVID-19 pandemic required urgency in the development and delivery of effective
vaccines and therapeutics; meanwhile, ongoing clinical research, regulation and supply for …

Innovation of medical products: the evolution of regulatory science, research, and education

P Spindler, KF Bach, M Schmiegelow… - Therapeutic …, 2016 - journals.sagepub.com
We present a commentary on the international aspects of the evolution of regulatory science
as a multidisciplinary, multistakeholder academic discipline of education and applied …